DAS-DDI: A dual-view framework with drug association and drug structure for drug-drug interaction prediction

被引:5
|
作者
Niu, Dongjiang [1 ]
Zhang, Lianwei [1 ]
Zhang, Beiyi [1 ]
Zhang, Qiang [1 ]
Li, Zhen [1 ]
机构
[1] Qingdao Univ, Coll Comp Sci & Technol, 308 NingXia Rd, Qingdao 266071, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
Drug-drug interaction; Dual-view; Drug association; Substructure; INJECTION;
D O I
10.1016/j.jbi.2024.104672
中图分类号
TP39 [计算机的应用];
学科分类号
081203 ; 0835 ;
摘要
In drug development and clinical application, drug-drug interaction (DDI) prediction is crucial for patient safety and therapeutic efficacy. However, traditional methods for DDI prediction often overlook the structural features of drugs and the complex interrelationships between them, which affect the accuracy and interpretability of the model. In this paper, a novel dual -view DDI prediction framework, DAS-DDI is proposed. Firstly, a drug association network is constructed based on similarity information among drugs, which could provide rich context information for DDI prediction. Subsequently, a novel drug substructure extraction method is proposed, which could update the features of nodes and chemical bonds simultaneously, improving the comprehensiveness of the feature. Furthermore, an attention mechanism is employed to fuse multiple drug embeddings from different views dynamically, enhancing the discriminative ability of the model in handling multi -view data. Comparative experiments on three public datasets demonstrate the superiority of DAS-DDI compared with other state-of-the-art models under two scenarios.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Hierarchical Structure-Aware Graph Prompting for Drug-Drug Interaction Prediction
    Ye, Yuhan
    Zhou, Jingbo
    Li, Shuangli
    Xiao, Congxi
    Ying, Haochao
    Xiong, Hui
    MACHINE LEARNING AND KNOWLEDGE DISCOVERY IN DATABASES-RESEARCH TRACK AND DEMO TRACK, PT VIII, ECML PKDD 2024, 2024, 14948 : 36 - 54
  • [42] APPLICATION OF A PHYSIOLOGICALLY BASED PHARMACOKINETIC (PBPK) MODEL FOR PREDICTION OF THE DRUG-DRUG INTERACTION (DDI) BETWEEN LORAZEPAM AND PROBENECID
    Neuhoff, Sibylle
    Musther, Helen
    Rowland-Yeo, Karen
    DRUG METABOLISM REVIEWS, 2015, 47 : 121 - 121
  • [43] DeSIDE-DDI: interpretable prediction of drug-drug interactions using drug-induced gene expressions
    Kim, Eunyoung
    Nam, Hojung
    JOURNAL OF CHEMINFORMATICS, 2022, 14 (01)
  • [44] DeSIDE-DDI: interpretable prediction of drug-drug interactions using drug-induced gene expressions
    Eunyoung Kim
    Hojung Nam
    Journal of Cheminformatics, 14
  • [45] Role of in vitro metabolic interactions in the conduct of drug-drug interaction (DDI) studies.
    Yuan, R
    Balian, JD
    Svadjian, R
    Uppoor, RS
    Ajayi, F
    Burnett, A
    Lesko, LJ
    Marroum, P
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 218 - 218
  • [46] DDI-MuG: Multi-aspect graphs for drug-drug interaction extraction
    Yang, Jie
    Ding, Yihao
    Long, Siqu
    Poon, Josiah
    Han, Soyeon Caren
    FRONTIERS IN DIGITAL HEALTH, 2023, 5
  • [47] PHARMACOKINETIC (PK) BASIS OF STATIN DRUG-DRUG INTERACTION (DDI) INFORMATION IN FDA LABELS
    Mease, J.
    Ramamoorthy, A.
    Yang, X.
    Madabushi, R.
    Fletcher, E. Pfuma
    Zineh, I.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S13 - S13
  • [48] Synthesis of stable isotopically labelled internal standards for drug-drug interaction (DDI) studies
    Zimmermann, J.
    Allen, J.
    Atzrodt, J.
    De-Bruin, B.
    Derdau, V.
    Gantz, D.
    Herbert, J.
    Raddatz, S.
    Roy, S.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2007, 50 (13-14): : 1277 - 1278
  • [49] Drug Repurposing Based on Drug-Drug Interaction
    Zhou, Bin
    Wang, Rong
    Wu, Ping
    Kong, De-Xin
    CHEMICAL BIOLOGY & DRUG DESIGN, 2015, 85 (02) : 137 - 144
  • [50] Understanding the Drug-Drug Interaction
    Yim, Dong-Seok
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2006, 49 (01): : 78 - 85